Position in NTRA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,069,784
+$309,822 QoQ
Shares Held
3,941
+3.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#436
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRAXIS INVESTMENT MANAGEMENT INC holds $25,418,048 across 17 Diagnostics & Research names. NTRA ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
18,872 | $9,461,665 | |
| 2 | DHR |
Danaher Corp /De/
|
26,657 | $5,077,625 | |
| 3 | DGX |
Quest Diagnostics Inc
|
8,530 | $1,807,933 | |
| 4 | LH |
Labcorp Holdings Inc.
|
4,820 | $1,349,600 | |
| 5 | NTRA |
Natera, Inc.
This page
|
3,941 | $1,069,784 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,700 | $894,948 | |
| 7 | WAT |
Waters Corp /De/
|
2,130 | $798,835 | |
| 8 | ILMN |
Illumina, Inc.
|
4,504 | $791,938 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,069,784 | 3,941 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $759,962 | 3,800 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $829,305 | 3,620 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $582,711 | 3,620 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $611,562 | 3,620 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $511,904 | 3,620 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $573,046 | 3,620 | Shares | Sole | 2025-01-03 | |
| No filing history on record for this holder in this stock. | ||||||